| Literature DB >> 31023248 |
Yasuko Nagamatsu1, Isao Oze2, Keisuke Aoe3, Katsuyuki Hotta4, Katsuya Kato5, Junko Nakagawa6, Keiko Hara6, Takumi Kishimoto7, Nobukazu Fujimoto8.
Abstract
BACKGROUND: Malignant pleural mesothelioma (MPM) is a fatal and rare disease that is caused by the inhalation of asbestos. Treatment and care requests made by MPM patients to their physicians were collected and analyzed.Entities:
Keywords: Asbestos; Communication; Mesothelioma; Patient-centered care; Support
Mesh:
Substances:
Year: 2019 PMID: 31023248 PMCID: PMC6485076 DOI: 10.1186/s12885-019-5591-7
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Demographic and Medical Characteristics of the Study Participants (N = 73)
| Characteristic | Response | n | % |
|---|---|---|---|
| Gender | Male | 61 | 83.6 |
| Female | 12 | 16.4 | |
| Age in years (mean ± SD) | 66.8 ± 11.3 | ||
| MPM Treatment Received | |||
| Surgery | I did not have | 43 | 58.9 |
| I had | 30 | 41.1 | |
| Chemotherapy | I never had | 13 | 17.8 |
| I had before | 29 | 39.7 | |
| I am having now | 31 | 42.5 | |
| Radiotherapy | I never had | 52 | 71.2 |
| I had before | 19 | 26.0 | |
| I am having now | 2 | 2.7 | |
| Palliative care | I never had | 39 | 53.4 |
| I had before | 9 | 12.3 | |
| I am having now | 25 | 34.2 | |
| ECOG Performance Status | 0 | 12 | 16.4 |
| 1 | 40 | 54.8 | |
| 2 | 7 | 9.6 | |
| 3 | 13 | 17.8 | |
| 4 | 1 | 1.4 | |
| Relationship with Their Physician | Very good | 30 | 41.1 |
| Good | 31 | 42.5 | |
| Moderate | 9 | 12.3 | |
| Not very good | 2 | 2.7 | |
| Poor | 1 | 1.4 | |
ECOG, Eastern Cooperative Oncology Group; SD, standard deviation
Requests to Physicians by MPM Patients (217 requests; N = 73)
| Categories | Times mentioned | % of Sample | |
|---|---|---|---|
| Subcategories | |||
| 1. Understandable explanation to meet the patient’s needs | 80 | ||
| 1.1 | Explain the cause of the symptoms, curability and prognosis of the disease, and provide a treatment plan | 41 | 56.2 |
| 1.2 | Use simple words | 12 | 16.4 |
| 1.3 | Explain the purpose, benefits, risk and results of examinations | 10 | 14.0 |
| 1.4 | Inform about all treatment options | 10 | 14.0 |
| 1.5 | Give advice about daily activities | 3 | 4.1 |
| 1.6 | Spend enough time on explanations | 2 | 2.7 |
| 1.7 | Confirm patient’s understanding and allow them to ask questions | 2 | 2.7 |
| 2. Patient-centered treatment | 39 | ||
| 2.1 | Minimize the physical impact of treatment | 11 | 15.1 |
| 2.2 | Do not give up on the treatment | 10 | 14.0 |
| 2.3 | Respect patient’s intention | 9 | 12.3 |
| 2.4 | Careful clinical assessment to not miss clinical signs of progression | 9 | 12.3 |
| 3. Improvement of treatment and support systems for MPM | 35 | ||
| 3.1 | Develop country-wide specialized care system | 16 | 21.9 |
| 3.2 | Develop new drugs | 10 | 14.0 |
| 3.3 | Improve information systems | 9 | 12.3 |
| 4. Emotional support | 32 | ||
| 4.1 | Be kind and cheerful | 11 | 15.1 |
| 4.2 | Sympathize with patient’s anxiety | 10 | 14.0 |
| 4.3 | Have a reliable attitude | 6 | 8.2 |
| 4.4 | Empathy for victims of asbestos | 3 | 4.1 |
| 4.5 | Visit patient as often as possible | 2 | 2.7 |
| 5. Customize “breaking the bad news” | 24 | ||
| 5.1 | Tell everything including bad news | 17 | 23.3 |
| 5.2 | Do not inform about bad news | 5 | 6.8 |
| 5.3 | Customize the contents and the way of informing | 2 | 2.7 |
| 6. Dedication to the treatment of MPM | 7 | ||
| 6.1 | Confront intractable disease | 4 | 5.4 |
| 6.2 | Learn about MPM | 3 | 4.1 |
MPM, malignant pleural mesothelioma